SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020405
Filing Date
2022-05-16
Accepted
2022-05-16 16:19:50
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20220331.htm   iXBRL 10-Q 2319624
2 EX-31.1 acer-ex311_6.htm EX-31.1 17671
3 EX-31.2 acer-ex312_8.htm EX-31.2 17710
4 EX-32.1 acer-ex321_9.htm EX-32.1 7885
5 EX-32.2 acer-ex322_7.htm EX-32.2 7525
6 GRAPHIC glf2qn11cgjn000001.jpg GRAPHIC 17440
  Complete submission text file 0001564590-22-020405.txt   8858569

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA acer-20220331.xsd EX-101.SCH 68017
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20220331_cal.xml EX-101.CAL 41766
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20220331_def.xml EX-101.DEF 257673
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20220331_lab.xml EX-101.LAB 510563
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20220331_pre.xml EX-101.PRE 407412
56 EXTRACTED XBRL INSTANCE DOCUMENT acer-10q_20220331_htm.xml XML 1395825
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 22929419
SIC: 2834 Pharmaceutical Preparations